Johnson & Johnson acquisitions hit close to $15bn - The Globe and Mail

Retrieved on: 2024-04-22 20:13:08

Tags for this article:

Click the tags to see associated articles and topics

Johnson & Johnson acquisitions hit close to $15bn - The Globe and Mail. View article details on HISWAI: https://www.theglobeandmail.com/investing/markets/indices/TTCS/pressreleases/25649696/johnson-johnson-acquisitions-hit-close-to-15bn/

Summary

Johnson & Johnson's aggressive expansion in biotechnology includes high-profile acquisitions like Ambrx Biopharma, focusing on antibody-drug conjugates, enhancing its oncology portfolio and consumer healthcare sectors.

Article found on: www.theglobeandmail.com

View Original Article